NeuroScientific Biopharmaceuticals Ltd (NSB):企業の財務・戦略的SWOT分析

◆英語タイトル:NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH3594142FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥33,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥49,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

NeuroScientific Biopharmaceuticals Ltd (NSB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NeuroScientific Biopharmaceuticals Ltd (NeuroScientific) develops novel pharmaceutical products that target neurological disorders which have high unmet medical needs. The company’s pipeline products include EmtinB therapeutic peptide which is being developed for the treatment of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s Disease and degenerative conditions of the optic nerve. The company has partnerships with various institute such as Lion’s Eye Institute, and Menzies Institute for Medical Research among others for research and the development of its pipeline product. NeuroScientific is headqutered in Nedlands, Western Australia, Australia.

NeuroScientific Biopharmaceuticals Ltd Key Recent Developments

Sep 25,2020: NeuroScientific Biopharmaceuticals : Change of Registered Office and Principal Place of Business Address
Sep 25,2020: NeuroScientific Biopharmaceuticals : Tax incentive rebate received
Jul 30,2020: NeuroScientific Biopharmaceuticals announces professor Dao-Yi Yu of Lions Eye Institute appointed to Scientific Advisory Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
NeuroScientific Biopharmaceuticals Ltd – Key Facts
NeuroScientific Biopharmaceuticals Ltd – Key Employees
NeuroScientific Biopharmaceuticals Ltd – Key Employee Biographies
NeuroScientific Biopharmaceuticals Ltd – Major Products and Services
NeuroScientific Biopharmaceuticals Ltd – History
NeuroScientific Biopharmaceuticals Ltd – Company Statement
NeuroScientific Biopharmaceuticals Ltd – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
NeuroScientific Biopharmaceuticals Ltd – Business Description
NeuroScientific Biopharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
NeuroScientific Biopharmaceuticals Ltd – Strengths
NeuroScientific Biopharmaceuticals Ltd – Weaknesses
NeuroScientific Biopharmaceuticals Ltd – Opportunities
NeuroScientific Biopharmaceuticals Ltd – Threats
NeuroScientific Biopharmaceuticals Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
NeuroScientific Biopharmaceuticals Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 25, 2020: NeuroScientific Biopharmaceuticals : Change of Registered Office and Principal Place of Business Address
Sep 25, 2020: NeuroScientific Biopharmaceuticals : Tax incentive rebate received
Jul 30, 2020: NeuroScientific Biopharmaceuticals announces professor Dao-Yi Yu of Lions Eye Institute appointed to Scientific Advisory Board
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
NeuroScientific Biopharmaceuticals Ltd, Key Facts
NeuroScientific Biopharmaceuticals Ltd, Key Employees
NeuroScientific Biopharmaceuticals Ltd, Key Employee Biographies
NeuroScientific Biopharmaceuticals Ltd, Major Products and Services
NeuroScientific Biopharmaceuticals Ltd, History
NeuroScientific Biopharmaceuticals Ltd, Key Competitors
NeuroScientific Biopharmaceuticals Ltd, Ratios based on current share price
NeuroScientific Biopharmaceuticals Ltd, Annual Ratios
NeuroScientific Biopharmaceuticals Ltd, Annual Ratios (Cont...1)
NeuroScientific Biopharmaceuticals Ltd, Interim Ratios
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
NeuroScientific Biopharmaceuticals Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[NeuroScientific Biopharmaceuticals Ltd (NSB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Trinity Biotech Plc (TRIB)-医療機器分野:企業M&A・提携分析
    Summary Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to dete …
  • Impact Developer & Contractor SA:企業の戦略・SWOT・財務情報
    Impact Developer & Contractor SA - Strategy, SWOT and Corporate Finance Report Summary Impact Developer & Contractor SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874):企業の財務・戦略的SWOT分析
    Summary Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (Guangzhou Baiyunshan Pharmaceutical) is a manufacturer of herbal medicine, chemical raw material medicine and preparation, biological medicine, and health products. The company also offers health medicines, health beverages, Chinese and we …
  • Mimetogen Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mimetogen Pharmaceuticals Inc (Mimetogen) is a clinical stage biotechnology company that develops the use of peptidomimetics for the treatment of ophthalmic diseases. The company’s lead compound, MIM-D3, which is in Phase 3 clinical study used for the treatment of dry eye syndrome. It also o …
  • NuScale Power LLC:企業の戦略的SWOT分析
    NuScale Power LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Teijin Limited:企業の戦略・SWOT・財務分析
    Teijin Limited - Strategy, SWOT and Corporate Finance Report Summary Teijin Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • AECOM (ACM):企業の財務・戦略的SWOT分析
    AECOM (ACM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the poten …
  • 10X Genomics, Inc.:製薬・医療:M&Aディール及び事業提携情報
    Summary 10X Genomics, Inc. (10X Genomics) is engaged in developing an innovative genomics platform. The company’s product pipeline comprises of chromium controller, single cell ATAC sequencer and single cell with barcode technology. It offers single cell gene expression, single cell immune profiling …
  • Carlsberg A/S:企業の戦略・SWOT・財務情報
    Carlsberg A/S - Strategy, SWOT and Corporate Finance Report Summary Carlsberg A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Intermountain Rural Electric Association:企業の発電所・SWOT分析2018
    Intermountain Rural Electric Association - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informa …
  • Tianjin Chase Sun Pharmaceutical Co Ltd (300026):製薬・医療:M&Aディール及び事業提携情報
    Summary Tianjin Chase Sun Pharmaceutical Co Ltd (Chase Sun) is a medicine and health industry group. The company research, develops, produces, and markets various pharmaceutical products. It offers products such as Chinese herb preparations, Chinese medicinal granules, synthetic drugs, biotech drugs …
  • Peter MacCallum Cancer Centre:製薬・医療:M&Aディール及び事業提携情報
    Summary Peter MacCallum Cancer Centre (Peter Mac) is a provider of public health services. It serves as a cancer research, treatment and education centre. The centre provides wide range of services including diagnostic, radiation therapy, treatment, cancer information and support services. It works …
  • NETGEAR Inc (NTGR):企業の財務・戦略的SWOT分析
    NETGEAR Inc (NTGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Internap Corp (INAP):企業の財務・戦略的SWOT分析
    Summary Internap Corp (Internap), formerly Internap Network Services Corp is an information technology company that provides internet infrastructure solutions. The company offers bare-metal cloud, hosting and colocation services. It provides collocation services such as power, interconnection, envir …
  • Theraclion SA (ALTHE):企業の財務・戦略的SWOT分析
    Summary Theraclion SA (Theraclion) is a medical device company that designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a syste …
  • Emera (Caribbean) Inc.:企業の戦略的SWOT分析
    Emera (Caribbean) Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Taylor-DeJongh Inc:企業の戦略・SWOT・財務情報
    Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report Summary Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kia Motors Corporation (000270):企業の財務・戦略的SWOT分析
    Kia Motors Corporation (000270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Principia Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Principia Biopharma Inc (Principia Biopharma) is a biopharmaceutical company that designs and develops oral small molecule drug therapies. The company’s proprietary Tailored Covalency technology helps to develop portfolio of drugs such as Bruton's tyrosine kinase (BTK) inhibitor, Interleukin …
  • Total Brain Ltd (TTB):企業の財務・戦略的SWOT分析
    Summary Total Brain Ltd (TBL) formerly, Brain Resource Ltd is a healthcare service provider that offers therapies. The company carries out research and development of brain products. TBL’s products comprise iSPOT, Total Brain and MyBrainSolutions. The company’s Total Brain is a brain health solution …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆